FDA applicant

Spatz Fgia, Inc.

Ft. Lauderdale1 decision2021–20210 recalls

FDA records 1 decision for Spatz Fgia, Inc. (Ft. Lauderdale) in 2021: 1 original PMA approval. All are in product code LTI (Implant, Intragastric For Morbid Obesity). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Spatz Fgia, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2021

2021high 1 (2021) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2021.

FIG. 1 — Spatz Fgia, Inc. by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Spatz Fgia, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Spatz Fgia, Inc.

Which product codes does it file in?

What has FDA decided for it lately?